EduBourseActualitésClinPhone and Cytel – A New Partnership Delivering Complete Solutions for Adaptive...

ClinPhone and Cytel – A New Partnership Delivering Complete Solutions for Adaptive Clinical Trials

Pierre Perrin-Monlouis Dernière mise à jour: 20 octobre 2021

(Nottingham, UK and Cambridge, USA 2 July 2008). ClinPhone, the world’s largest Clinical Technology Organization (CTO) and Cytel Inc., leading statistical experts in adaptive clinical trials, announced today a unique partnership that unites Cytel’s validated adaptive trial statistical and computational expertise with ClinPhone’s robust suite of clinical technologies and operational know-how.

This new partnership offers sponsors the combined expertise of the two organizations in successful design, planning and implementation of adaptive and other complex study designs. ClinPhone-Cytel adaptive trial solutions are tailored to the requirements and objectives of each individual clinical development program. This integrated service provides all the essential components for adaptive trial planning and implementation, including study design consulting, trial simulations, supplies planning and management, clinical data collection, randomization, trial supply management, data analysis and reporting.

Adaptive Clinical Trials (ACTs) refer to clinical studies that use accumulating response data to optimize pre-determined aspects of the study design without undermining the validity and integrity of the trial. By making mid-course adjustments to the trial, adaptive trials increase the ability to answer the study’s key research objectives, and improve the likelihood of a successful outcome. ClinPhone-Cytel solutions combine the innovative statistical techniques and trial technology advances that make designing and conducting adaptive trials practical for sponsor organizations of all sizes.

Irving Dark, Cytel’s Vice President of Clinical Research Services explains, “The ClinPhone-Cytel collaboration provides sponsors with the full-service offering needed for successful Adaptive Clinical Trials. This partnership underscores our commitment to be the leader in innovative trial design and implementation services.”

Dr. Bill Byrom, Vice President, Product Strategy and Marketing of ClinPhone comments, “Technology plays a central role in delivering these types of studies, and Cytel and ClinPhone together are leading the way in offering integrated services that provide a comprehensive solution for the sponsor wishing to benefit from the power of adaptive trials.”

To learn more about ClinPhone’s clinical trial technology solutions, please visit, or alternatively e-mail [email protected]

To learn more about Cytel Inc, please visit, or alternatively e-mail [email protected]

About ClinPhone
ClinPhone plc is the world’s largest Clinical Technology Organization (CTO) with an unrivaled track record of innovation in the development of clinical trial technology. Headquartered in Nottingham UK with offices around the world, ClinPhone works with leading global biotechnology organizations, pharmaceutical companies and Contract Research Organizations (CROs).

ClinPhone is the largest and most accomplished CTO with experience in over 2,000 clinical trials spanning 88 countries and 71 languages. The Company’s experience includes Phase I to Phase IV studies, ranging from single center studies with 20 patients to “mega trials” with over 40,000 patients.

ClinPhone’s product portfolio, consisting of software and services, is backed by continuous research and investment in the latest technologies, coupled with extensive in-depth clinical industry experience. Its industry-leading software solutions include electronic data capture (EDC) and clinical trial management systems (CTMS), which can be licensed or implemented as hosted solutions. Delivered via its renowned Interactive Voice Response (IVR) and Interactive Web Response (IWR) platform, ClinPhone offers randomization, trial supply management, trial supply simulation, electronic patient reported outcomes (ePRO), and patient recruitment solutions.

ClinPhone’s products can integrate, taking the pain out of juggling and managing multiple sources of disparate information. This approach provides more control over data, improves data integrity and streamlines the data validation process.

About Cytel
Cytel pioneered the statistical science and computational technology of adaptive clinical trials. Benefiting both sponsors and patients, Cytel has designed more validated adaptive trials than anyone else.

Biopharmaceutical and device companies of all sizes turn to the clinical study planning, simulation and implementation experience of Cytel. Cytel experts have trained thousands of health sciences industry biostatisticians, clinicians, and regulatory staff in the latest trial design techniques.

Cytel’s Pharmaceutical Research Services place this clinical study innovation experience at the disposal of your research and development programs. From trial simulation and process development to independent data assessment and regulatory review, Cytel stands with you every step of the way.

For further press information contact: Fiona Robinson, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom Tel: + 44 1477 539539. Fax: +44 1477 539540 E:[email protected]

Contact Information:
Charlotte Culley/Fiona Robinson
The Scott Partnership
Phone: +44 (0) 1477 539539
E-mail: [email protected]

Kathleen Pomykola
ClinPhone plc
Phone: +1 609 524 4242
E-mail: [email protected]

Michael Weitz
Cytel Inc
Phone: +1 617 661 2011
E-mail: [email protected]

Pierre Perrin-Monlouis
Pierre Perrin-Monlouis
Fondateur de Rente et Patrimoine (cabinet de gestion de patrimoine), Pierre Perrin-Monlouis est un analyste et trader pour compte propre. Il vous fait profiter de son expérience en trading grâce à ses analyses financières et décrypte pour vous les actualités des marchés. Son approche globale des marchés combine à la fois l'analyse technique et l'analyse fondamentale sur l'ensemble des marchés : crypto, forex, actions et matières premières.